|
ZNF250 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.159850E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.424650E-03 |
| Normal-vs-Stage2 |
2.116700E-03 |
| Normal-vs-Stage3 |
1.09110000001689E-06 |
| Normal-vs-Stage4 |
4.21110000000668E-05 |
| Stage1-vs-Stage2 |
6.152400E-01 |
| Stage1-vs-Stage3 |
5.83659999999764E-05 |
| Stage1-vs-Stage4 |
2.658300E-02 |
| Stage2-vs-Stage3 |
4.908500E-02 |
| Stage2-vs-Stage4 |
2.426800E-01 |
| Stage3-vs-Stage4 |
4.257400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.09319999999935E-05 |
| Normal-vs-AfricanAmerican |
4.257700E-02 |
| Normal-vs-Asian |
6.797000E-01 |
| Caucasian-vs-AfricanAmerican |
7.939500E-02 |
| Caucasian-vs-Asian |
5.028600E-04 |
| AfricanAmerican-vs-Asian |
1.070970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.9323E-05 |
| Normal-vs-Female |
6.757000E-04 |
| Male-vs-Female |
1.895750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.060400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.778800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.05340000000365E-05 |
| Normal-vs-Age(81-100Yrs) |
1.117820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.813200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.184400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.945600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.188170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.231400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.633000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.418800E-01 |
| Normal-vs-Grade 2 |
3.520700E-03 |
| Normal-vs-Grade 3 |
2.09029999999055E-05 |
| Normal-vs-Grade 4 |
1.83180000057348E-08 |
| Grade 1-vs-Grade 2 |
4.430400E-02 |
| Grade 1-vs-Grade 3 |
2.200000E-04 |
| Grade 1-vs-Grade 4 |
2.19190000039227E-07 |
| Grade 2-vs-Grade 3 |
9.438800E-04 |
| Grade 2-vs-Grade 4 |
9.13950004566288E-09 |
| Grade 3-vs-Grade 4 |
1.020430E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.810500E-04 |
| Normal-vs-ccB subtype |
5.613399999993E-05 |
| ccA subtype-vs-ccB subtype |
3.472100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.54029999999939E-05 |
| Normal-vs-N1 |
1.057830E-02 |
| N0-vs-N1 |
2.494800E-01 |
|
|
